{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:10:31Z","timestamp":1790892631423,"version":"4.1.0"},"reference-count":42,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Introduction: Valproic acid (VPA) is an antiepileptic drug extensively used for treating partial and generalised seizures, acute mania and as prophylaxis for bipolar disorder. Drug-induced liver injury (DILI) persists as a significant issue related to fatal outcomes by VPA. The aim of this study was to increase our knowledge about this condition and to better identify patients affected. Methods: We conducted an observational retrospective case-control study that identified cases of DILI by VPA from the Pharmacovigilance Programme from our Laboratory Signals at La Paz University Hospital from January 2007 to December 2019. From the Therapeutic VPA Monitoring program, two control groups were assigned, VPA-tolerant patients and the other with patients who developed mild VPA-related liver injury but who did not meet the DILI criteria, matched for date, age and sex. Results: A total of 60 patients were included in the study: 15 cases of DILI, 30 VPA-tolerant controls and 15 controls with mild liver injury. Mean age for the cases was 45.7 years, 4 (26.7%) were women and 5 (33.34%) were children under 18 years, of them 3 (20%) were fatal. Polytherapy with other antiepileptic drugs (p = 0.047) and alcohol consumption (p &lt; 0.001) were associated with a greater risk of developing DILI by VPA. A diagnosis of epileptic seizure was more frequently related to DILI when compared with the VPA-tolerant controls (p &lt; 0.001). The cases developed hepatocellular liver injury (p &lt; 0.001), while the mild hepatic damage controls had a higher rate of cholestatic liver injury (p &lt; 0.001). The laboratory lactate dehydrogenase values were statistically higher (even at baseline) in patients with DILI than in both control groups (p = 0.033 and p = 0.039). Conclusions: VPA hepatotoxicity remains a considerable problem. This study offers interesting findings for characterising VPA-induced liver injury and at-risk patients.<\/jats:p>","DOI":"10.3390\/jcm10061153","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T13:27:20Z","timestamp":1615382840000},"page":"1153","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Valproic Acid-Induced Liver Injury: A Case-Control Study from a Prospective Pharmacovigilance Program in a Tertiary Hospital"],"prefix":"10.3390","volume":"10","author":[{"given":"Enrique S.","family":"Meseguer","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6951-5518","authenticated-orcid":false,"given":"Mikel U.","family":"Elizalde","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8584-3263","authenticated-orcid":false,"given":"Alberto M.","family":"Borobia","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4052-8876","authenticated-orcid":false,"given":"Elena","family":"Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2710.2005.00671.x","article-title":"Valproate: A simple chemical with so much to offer","volume":"30","author":"Peterson","year":"2005","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_2","unstructured":"Sztajnkrycer, M.D. (2020). Valproic Acid Poisoning, UpToDate. Available online: www.uptodate.com\/contents\/valproic-acid-poisoning?search=valproic-acid&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/1570159X17666181227165722","article-title":"Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences","volume":"17","author":"Romoli","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Mu\u00f1oz, F., Shen, W.W., D\u2019Ocon, P., Romero, A., and \u00c1lamo, C. (2018). A History of the Pharmacological Treatment of Bipolar Disorder. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19072143"},{"key":"ref_5","unstructured":"CIMA (1995). DEPAKINE Crono 300 mg. Summary Product Characteristics, CIMA. Available online: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/60351\/FT_60351.html."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic Pharmacology of Valproate","volume":"16","year":"2002","journal-title":"CNS Drugs"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and Therapeutic Properties of Valproate","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00213-006-0317-3","article-title":"Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex","volume":"185","author":"Gobbi","year":"2006","journal-title":"Psychopharmacology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0006-8993(91)90078-A","article-title":"Valproate suppresses N-methyl-d-aspartate-evoked, transient depolarizations in the rat neocortex in vitro","volume":"544","author":"Zeise","year":"1991","journal-title":"Brain Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(99)00517-8","article-title":"Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation","volume":"380","author":"Ichikawa","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/jhg.2017.91","article-title":"The pharmacogenomics of valproic acid","volume":"62","author":"Zhu","year":"2017","journal-title":"J. Hum. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0006-2952(93)90404-K","article-title":"Valproate and mitochondria","volume":"46","author":"Ponchaut","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinbiochem.2013.06.012","article-title":"Adverse drug reactions induced by valproic acid","volume":"46","author":"Nanau","year":"2013","journal-title":"Clin. Biochem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1381612825666190329145428","article-title":"Valproic Acid and the Liver Injury in Patients with Epilepsy: An Update","volume":"25","author":"Guo","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/clpt.2009.185","article-title":"A Pharmacovigilance Program from Laboratory Signals for the Detection and Reporting of Serious Adverse Drug Reactions in Hospitalized Patients","volume":"87","author":"Ramirez","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12072-017-9793-2","article-title":"CSH guidelines for the diagnosis and treatment of drug-induced liver injury","volume":"11","author":"Yu","year":"2017","journal-title":"Hepatol. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case Definition and Phenotype Standardization in Drug-Induced Liver Injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2014I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J. Clin. Epidemiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s40264-018-0654-2","article-title":"Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?","volume":"41","author":"Danan","year":"2018","journal-title":"Drug Saf."},{"key":"ref_20","unstructured":"IMIM (2012). Sample Size Calculator, IMIM. Available online: www.imim.es\/ofertadeserveis\/software-public\/granmo\/."},{"key":"ref_21","unstructured":"ECIJA (2018). Organic law 3\/2018, December 5, 2018, Protection of Personal Data and Guarantee of Digital Rights, ECIJA. Available online: https:\/\/apdcat.gencat.cat\/web\/.content\/01-autoritat\/normativa\/documentos\/Llei-organica-pd-2018.pdf."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1055\/s-0032-1323671","article-title":"Non-Fatal and Fatal Liver Failure Associated with Valproic Acid","volume":"46","author":"Schmid","year":"2012","journal-title":"Pharmacopsychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Star, K., Edwards, I.R., and Choonara, I. (2014). Valproic Acid and Fatalities in Children: A Review of Individual Case Safety Reports in VigiBase. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0108970"},{"key":"ref_24","first-page":"890","article-title":"Valproic acid-induced idiosyncratic liver injury in 4 cases","volume":"50","author":"Xiong","year":"2012","journal-title":"Chin. J. Pediatr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0950-3528(88)90009-7","article-title":"8 Acute and chronic drug-induced hepatitis","volume":"2","author":"Pessayre","year":"1988","journal-title":"Bailli\u00e8re Clin. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/liv.13662","article-title":"Drug-induced acute liver failure in children and adults: Results of a single-centre study of 128 patients","volume":"38","author":"Devarbhavi","year":"2017","journal-title":"Liver Int."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Walker, C.P., and Deb, S. (2019). Rhabdomyolysis and Hepatotoxicity from Valproic Acid: Case Reports. J. Pharm. Pract., 0897190019882880.","DOI":"10.1177\/0897190019882880"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14652","DOI":"10.3748\/wjg.v20.i40.14652","article-title":"Alcoholic disease: Liver and beyond","volume":"20","author":"Rocco","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1530-0277.1991.tb00518.x","article-title":"Alcoholic Liver Disease: Pathologic, Pathogenetic and Clinical Aspects","volume":"15","author":"Ishak","year":"1991","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1515\/bc.2010.137","article-title":"Mechanisms and cell signaling in alcoholic liver disease","volume":"391","author":"Beier","year":"2010","journal-title":"Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tiv.2012.01.020","article-title":"A new approach on valproic acid induced hepatotoxicity: Involvement of lysosomal membrane leakiness and cellular proteolysis","volume":"26","author":"Pourahmad","year":"2012","journal-title":"Toxicol. Vitr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/AAC.00854-16","article-title":"Role of Inflammatory and Oxidative Stress, Cytochrome P450 2E1, and Bile Acid Disturbance in Rat Liver Injury Induced by Isoniazid and Lipopolysaccharide Cotreatment","volume":"60","author":"Hassan","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0009-9120(01)00217-X","article-title":"CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity","volume":"34","author":"Neuman","year":"2001","journal-title":"Clin. Biochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.410140107","article-title":"Plasma concentrations of sodium valproate: Their clinical value","volume":"14","author":"Turnbull","year":"1983","journal-title":"Ann. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00003088-198510020-00003","article-title":"Concentration-Effect Relationships of Valproic Acid","volume":"10","author":"Chadwick","year":"1985","journal-title":"Clin. Pharmacokinet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugsbest practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0168-1656(92)90158-6","article-title":"Lactate dehydrogenase (LDH) activity of the number of dead cells in the medium of cultured eukaryotic cells as marker","volume":"25","author":"Legrand","year":"1992","journal-title":"J. Biotechnol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-62703-290-2_7","article-title":"Detection of Necrosis by Release of Lactate Dehydrogenase Activity","volume":"979","author":"Chan","year":"2013","journal-title":"Method Mol. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00228-012-1277-7","article-title":"Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients","volume":"68","author":"Chu","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/toxsci\/kfl096","article-title":"Contribution of CYP2C9, CYP2A6, and CYP2B6 to Valproic Acid Metabolism in Hepatic Microsomes from Individuals with the CYP2C9*1\/*1 Genotype","volume":"94","author":"Kiang","year":"2006","journal-title":"Toxicol. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3109\/15376516.2010.497977","article-title":"Influence of CYP2C9 polymorphism on metabolism of valproate and its hepatotoxin metabolite in Iranian patients","volume":"20","author":"Ghahremani","year":"2010","journal-title":"Toxicol. Mech. Methods"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.seizure.2010.01.002","article-title":"POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders","volume":"19","author":"Saneto","year":"2010","journal-title":"Seizure"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/6\/1153\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:35:53Z","timestamp":1760160953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/6\/1153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["jcm10061153"],"URL":"https:\/\/doi.org\/10.3390\/jcm10061153","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202101.0316.v1","asserted-by":"object"}]},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]}}}